Device manufactured by Camgenium aids high-risk pregnant women with pre-eclampsia condition.
In a significant stride towards empowering pregnant women and enhancing health outcomes, Camgenium's innovative medical device software, 'Reassure Pregnancy', has been making waves in the healthcare sector. This at-home monitoring solution, built on Camgenium's flexible, no-code Xenplate software platform, is designed specifically for pregnant women at risk of pre-eclampsia.
Reassure Pregnancy has been developed to put control back into the hands of women, allowing them to proactively monitor their health throughout pregnancy. The app enables frequent testing, saving time and cost for clinics and ensuring that clinicians can take action at the first sign of a problem.
Pre-eclampsia, a medical condition characterised by high blood pressure and the presence of protein in urine, poses a significant risk to both mothers and their unborn children. Reassure Pregnancy allows women to track key indicators such as blood pressure using a simple app, and data is shared in real-time with clinicians via a dashboard.
The app's success is evident in its current use at Milton Keynes University Hospital NHS Foundation Trust and University Hospitals Dorset in Poole. Camgenium, certified to ISO 13485 and approved by the NHS to host websites on HSCN, the NHS private network, has also donated blood pressure monitors to these hospitals to make Reassure Pregnancy available to more women.
In addition to Reassure Pregnancy, at-home medical devices for monitoring pre-eclampsia symptoms primarily focus on tracking key indicators such as blood pressure and other vital signs. Automated blood pressure monitors and wearable devices for continuous vital signs monitoring are the main at-home tools currently available, with remote biochemical tests like salivary uric acid testing representing promising future options still undergoing clinical validation.
Early diagnosis and management of pre-eclampsia are essential for preventing maternal and neonatal complications. The successful and prolonged use of Reassure Pregnancy in maternity clinics demonstrates its potential to improve health outcomes for pregnant women and their unborn children.
Camgenium plans to introduce Reassure Pregnancy to further NHS hospital trusts in the coming months, with the model already set at Milton Keynes University Hospital and University Hospitals Dorset serving as a potential blueprint for wider implementation. Patient confidentiality is maintained and secure with the use of Camgenium's systems, ensuring that women can monitor their health with peace of mind.
Reassure Pregnancy is an inclusive and accessible app, available in multiple languages, making it a valuable tool for women across the UK. As Camgenium continues to innovate and improve, the future of at-home healthcare for pregnant women looks bright.
- The 'Reassure Pregnancy' app, a breakthrough in femtech news, is designed to monitor health in pregnant women at risk of pre-eclampsia, enabling frequent testing and real-time data sharing with clinicians.
- Camgenium's innovative medical device, 'Reassure Pregnancy', functioning in the realm of science and medical-conditions, tracks key indicators such as blood pressure, targeting chronic diseases like pre-eclampsia and contributing to health-and-wellness in women's health.
- The success of 'Reassure Pregnancy' is demonstrated in its adoption at Milton Keynes University Hospital NHS Foundation Trust and University Hospitals Dorset, marking a significant step towards patient care and empowerment in womens-health.
- Future advancements in at-home healthcare for pregnant women may include remote biochemical tests and wearable devices for continuous vital signs monitoring, aiming to improve early diagnosis and management of chronic diseases like pre-eclampsia.
